Noetic
Venture capitalToronto · Seed–Series A · 13 people tracked
Also known as GREY HOUSE PARTNERS GP INC. · Noetic (US) · Noetic Psychedelic
Find your way into Noetic
1,077 people in our graph share verified history with the Noetic team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Noetic invests in early-stage technologies aimed at improving mental, emotional, and physiological health. Its diversified, multi-modal strategy spans novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables, and other evidence-backed solutions. The firm takes a global outlook, focusing on CNS-targeted therapeutics and sustainable solutions that address the root causes of illness while emphasizing early intervention and prevention. Noetic seeks teams with the skills, expertise, management experience, and governance structures to build world-class companies, and is committed to developing therapies, products, and services that are innovative, safe, and accessible for current and future generations.
Source: firm website, verified Sep 15, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 23 of 38 portfolio companiesBiotech ×16Digital Health ×14Healthtech ×12Mental Health ×11Medical Devices ×6Wellness & Fitness ×6Deep Tech ×5AI & Machine Learning ×3
HQs:United States×7Canada×2United Kingdom×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×92 founders×44+ founders×1
What their founders studiedfrom 13 founders with field-of-study data
Life Sciences ×5Finance & Accounting ×3Law ×3Social Sciences ×3Business & Management ×2Chemistry ×2Humanities ×2Medicine ×2
Where their founders worked beforefrom 16 founders with career history
Columbia University in the City of New York ×2Gilgamesh Pharma ×2
Investments · 38 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 12 dated
Compass Pathways develops novel treatments for mental health conditions, with a focus on psychedelic-assisted therapies supported by rigorous clinical research.
BiotechDigital HealthHealthtechMedical DevicesMental Health
Kabir Nath(CEO)
Co-investorsAble PartnersAisling CapitalCatalio Capital Management, LPOMX VenturesVivo CapitalJam Fund
Helus Pharma (branded Cybin) is a clinical-stage biotech developing novel serotonergic agonist therapies for mental health conditions, with lead programs including CYB004 in Phase 2 trials for generalized anxiety disorder.
BiotechDigital HealthMental HealthToronto
Eric So(Co-Founder, Executive Chairman & Interim CEO)inPaul Glavine(Director, Executive Officer)inGabriel Fahel(Executive Officer)George Tziras(Director, Executive Officer)inAaron Bartlone(Executive Officer)inGreg Cavers(Executive Officer)in
Co-investorsInnovating CapitalJLS
Apollo Neuro makes a wearable device that delivers gentle vibrations ("SmartVibes") intended to balance the autonomic nervous system, aiming to reduce stress, improve sleep, focus, and recovery.
Digital HealthHardwareWellness & Fitness
Kathryn Fantauzzi(Founder)in
Co-investorsID8 InvestmentsPortfoliaB CapitalBain Capital VenturesNexus Venture PartnersSequoia Capital+1 more
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao
Co-investorsFJ LabsIter InvestmentsLeafy TunnelRedbus VenturesWhat If VenturesPsyMed Ventures
CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening.
BiotechDeep TechMental Health
Andrew Chadeayne(Founder & CEO)inDavis Wuolle(Chief Technology Officer & Chief Marketing Officer)in
Co-investorsKortschak Investments L.P.
Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.
BiotechDeep TechDigital HealthHealthtechMedical Devices
Co-investorsAngelini VenturesLumira VenturesToronto Innovation Acceleration Partners
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
Co-investorsArtis VenturesCasa Verde CapitalOMX VenturesPsyMed VenturesRA CapitalVertical Venture Partners+6 more
Diamond Therapeutics is a preclinical biotechnology company developing drug treatments for psychiatric and neurological disorders, with a focus on the pharmacology and therapeutic use of psychedelic compounds.
BiotechHealthtechMental HealthToronto, CA
Judy Blumstock(Chief Executive Officer, Founder, Director)inMichael B. McDonnell(Chief Medical Officer)Grant McCutcheon(Chief Financial Officer)in
Co-investorsJLS
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)in
Co-investorsAera VCFrontera Technology VenturesFrontier Path VCJames Beshara FundJLSMagnetic Ventures+10 more
Merlyn builds AI-based solutions designed for education, aimed at schools and classrooms.
AI & Machine LearningEdTech
Co-investorsWestern Technology InvestmentLearn Capital
MindMed is a biotech company developing psychedelic-based therapeutics, including a proprietary orally disintegrating LSD tablet (DT120) and an R-enantiomer of MDMA (DT402), to treat brain health disorders such as generalized anxiety disorder, major depressive disorder, PTSD, and autism spectrum disorder.
BiotechDigital HealthMental Health
Co-investorsDaft CapitalK2 HealthVentures
People Science runs real-world clinical research for the health and wellness industry, offering a decentralized clinical trial platform (Chloe Clinical) and a real-world data collection tool (Chloe LiveLab) alongside clinical research services.
Digital HealthHealthtechWellness & Fitness
Noah Craft(Founder)in
Co-investorsAcre Venture PartnersFTW VenturesLifeforce CapitalBluestein VenturesSUPPLY CHANGE CAPITAL
Psych Central is a digital publisher providing informational content on mental health, wellness, and medical topics developed in collaboration with licensed medical professionals.
Digital HealthHealthtechMedia & EntertainmentMental HealthWellness & Fitness
Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use.
BiotechDeep TechHealthtechMedical DevicesMental Health
Danny Motyka(Co-Founder & CEO)inPeter van der Heyden(Co-Founder & Director)in
Co-investorsIter InvestmentsEight Capital
Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.
Digital HealthHealthtechMedical DevicesMental HealthLafayette, US
Richard Hanbury(Founder)in
Co-investorsCheckmate Capital Group LLCClick VenturesFlucas VenturesHarmonix FundHealthtech CapitalMarram Ventures+5 more
A psychedelics research organization that discovers new psychoactive substances and develops compounds and delivery systems for therapeutic use, continuing the work of Dr.
BiotechDeep TechDigital Health
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.
BiotechDeep TechHealthtech
Matthew Baggott(CEO)in
Co-investorsLeafy TunnelPsyMed Ventures10X CapitalPalo SantoWefunder
Terran Biosciences is a biotech platform company developing therapeutics and technologies for neurological and psychiatric diseases, including late-stage drug candidates for schizophrenia, psychedelic and empathogen compounds, and an AI-based neuromelanin MRI analysis platform.
AI & Machine LearningBiotechDigital Health
Sam Clark(Chief Executive Officer)Dustin Tetzl(Chief Business Officer)
Co-investorsPsyMed VenturesRed Beard Ventures
Vessel Health offers at-home urine testing and health monitoring solutions designed to help users track and improve their wellness.
Digital HealthHealthtechWellness & FitnessSan Diego, US
Jon Carder(Executive Officer, Director)in
BoardJared Stein(Director)
Co-investorsCove FundInterlock CapitalMoore Venture PartnersCity Light
Wake offers medicinal and psychedelic fungi therapy combined with genomics-based integration aimed at supporting human health and personal transformation.
BiotechHealthtechWellness & Fitness
Nick Murray(Founder)in
Woven Science backs, incubates, and builds companies in the psychedelic and wellness space, operating across drug development, health technology, and plant-medicine product development and distribution.
BiotechMental HealthWellness & Fitness
Nick von Christierson(CEO & Co-Founder)inGiles Hayward(President & Co-Founder)inRiwa Harfoush(Chief Strategy Officer)inLouis Sagar(Chief Experience Officer)inHelen Sartory(Chief Financial Officer)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Apollo NeuroscienceAccesswireAlexander Shulgin Research InstituteApaBexson BiomedicalEleusisEleusisltdNuminusNuminuswellnessPsyBio TherapeuticsPsybiolifePsychedelic Drugs KPMGstate capital gainsTerran BiosciencesVesselWoven Science
Exits · 2
2 IPOsCompass PathwaysNASDAQ: CMPSCybinNASDAQ: HELP
Portfolio news
latest coverage across their companiesApollo · bloomberg.com · Aug 24, 2026
Cybin · tickerreport.com · Aug 23, 2026
Beckley Psytech · wmbdradio.com · Jul 16, 2026
Gilgamesh Pharmaceuticals · wmbdradio.com · Jul 16, 2026
Delix · ucdavis.edu · Sep 10, 2025
Frequently asked questions
- How many investments has Noetic made?
- Noetic has 38 tracked investments, 2 of which have exited.
- What stage does Noetic invest at?
- Noetic invests at the Seed, Series A stages.
- What sectors does Noetic focus on?
- Noetic focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health, Wellness & Fitness.
- Where is Noetic located?
- Noetic is headquartered in Toronto, CA.
- Does Noetic lead rounds?
- Yes, Noetic leads investment rounds.
- Who does Noetic co-invest with?
- Noetic most often shares deals with PsyMed Ventures, JLS, Moore Venture Partners, among 54 tracked co-investors.
Media · Podcasts & interviews
featuring the teamSa'ad Shah, Investing $150M to Fix The Mental Health Crisis With Noetic Capital | Brick By Brick 014
Ollie Allen Fox · Sa'ad Shah
#opnaskaninvestor - Sa'ad Shah, Managing Partner, Noetic Fund
Open People Network · Sa'ad Shah
Images
Similar investors
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
PsyMed Ventures is an early-stage venture firm investing in neuroscience and frontier technologies aimed at improving brain and mental health.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
SteelSky Ventures is an AI-focused healthcare venture fund that backs companies opening new markets and advancing healthcare innovation, with an emphasis on women's health and health equity.